{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:26:46Z","timestamp":1788200806901,"version":"build-2803163510"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"73","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cervical cancer remains a public health problem, with the highest burden in low- and middle-income countries (LMICs). As vaccinated cohorts reach screening age, most modeling and policy discussions about the relationship between screening and vaccination have focused on high-income countries, early adopters of human papillomavirus (HPV) vaccination with robust, well-established cervical cancer screening programs. Challenges and solutions proposed for these settings are not necessarily applicable to LMICs, which have historically lagged in cancer prevention and operate within more constrained health systems. We analyze HPV vaccination patterns by country-level income and highlight inequities across program rollout and coverage. Using 6 LMICs expected to screen vaccinated cohorts before 2030, we outline financial, health-system, and information-system challenges. We examine how mathematical models may guide screening policies and illustrate, through Costa Rica\u2019s experience, how research can support implementation of cervical cancer elimination interventions. LMICs will need cost-effective risk-stratified screening approaches tailored to local resources as cervical cancer risk declines over coming years. However, because many women more than 30\u2009years old have not been vaccinated and remain at risk of developing cervical cancer, global efforts to ensure good-quality screening are crucial.<\/jats:p>","DOI":"10.1093\/jncimonographs\/lgag009","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:25:46Z","timestamp":1777289146000},"page":"155-163","source":"Crossref","is-referenced-by-count":1,"title":["Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries"],"prefix":"10.1093","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-8323","authenticated-orcid":false,"given":"Maribel","family":"Almonte","sequence":"first","affiliation":[{"name":"Department of Noncommunicable Diseases and Mental Health, World Health Organization , Geneva,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-5289","authenticated-orcid":false,"given":"Romina A","family":"Tejada","sequence":"additional","affiliation":[{"name":"Centre de recherche Azrieli, CHU Sainte-Justine , Montr\u00e9al, Qu\u00e9bec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0050-9555","authenticated-orcid":false,"given":"Alejandro","family":"Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Health and Social Security Research Area, Caja Costarricense del Seguro Social , San Jos\u00e9,","place":["Costa Rica"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8717-6911","authenticated-orcid":false,"given":"Armando","family":"Baena","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026083104014561400_lgag009-B1","author":"Ferlay"},{"key":"2026083104014561400_lgag009-B2","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026083104014561400_lgag009-B3","doi-asserted-by":"publisher","first-page":"100812","DOI":"10.1016\/j.lana.2024.100812","article-title":"From commitments to action: the first global cervical cancer elimination forum","volume":"36","author":"Almonte","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"2026083104014561400_lgag009-B4"},{"key":"2026083104014561400_lgag009-B5","first-page":"645","year":"2022"},{"key":"2026083104014561400_lgag009-B6","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","article-title":"Noninferiority of one HPV vaccine dose to two doses","volume":"393","author":"Kreimer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026083104014561400_lgag009-B7","volume-title":"Human Papillomavirus (HPV) Self-Sampling as Part of Cervical Cancer Screening and Treatment, 2022 Update","author":"WHO recommendations on self-care interventions"},{"key":"2026083104014561400_lgag009-B8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2147\/IJWH.S474571","article-title":"The future of cervical cancer screening","volume":"16","author":"Goldstein","year":"2024","journal-title":"Int J Womens Health"},{"key":"2026083104014561400_lgag009-B9","author":"World Health Organization"},{"key":"2026083104014561400_lgag009-B10","author":"World Health Organization"},{"key":"2026083104014561400_lgag009-B11","doi-asserted-by":"publisher","first-page":"106399","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"key":"2026083104014561400_lgag009-B12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"2026083104014561400_lgag009-B13","doi-asserted-by":"publisher","first-page":"e077341","DOI":"10.1136\/bmj-2023-077341","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"2026083104014561400_lgag009-B14","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Use of human papillomavirus (HPV) DNA genotyping","year":"2026"},{"key":"2026083104014561400_lgag009-B15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2165\/00019053-200422130-00004","article-title":"A decision chart for assessing and improving the transferability of economic evaluation results between countries","volume":"22","author":"Welte","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"2026083104014561400_lgag009-B16","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026083104014561400_lgag009-B17","author":"World Health Organization"},{"key":"2026083104014561400_lgag009-B18","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.lansea.2024.100370","article-title":"Population-level cancer screening and cancer care in Bhutan, 2020-2023: a review","volume":"24","author":"Dorji","year":"2024","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2026083104014561400_lgag009-B19"},{"key":"2026083104014561400_lgag009-B20"},{"key":"2026083104014561400_lgag009-B21","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.7314\/apjcp.2015.16.8.3435","article-title":"Mapping HPV vaccination and cervical cancer screening practice in the pacific region-strengthening national and regional cervical cancer prevention","volume":"16","author":"Obel","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026083104014561400_lgag009-B22","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.1016\/j.lana.2023.100593","article-title":"Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study","volume":"26","author":"Ramirez","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"2026083104014561400_lgag009-B23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1001\/jama.294.17.2173","article-title":"Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial","volume":"294","author":"Denny","year":"2005","journal-title":"JAMA"},{"key":"2026083104014561400_lgag009-B24","doi-asserted-by":"publisher","first-page":"e0115355","DOI":"10.1371\/journal.pone.0115355","article-title":"Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru","volume":"10","author":"Almonte","year":"2015","journal-title":"PLoS One"},{"key":"2026083104014561400_lgag009-B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid2701.191364","article-title":"Impact of human papillomavirus vaccination, Rwanda and Bhutan","volume":"27","author":"Baussano","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2026083104014561400_lgag009-B26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.7326\/M20-2849","article-title":"Prevalence of human papillomavirus and estimation of human papillomavirus vaccine effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018: a cross-sectional study","volume":"173","author":"Baussano","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026083104014561400_lgag009-B27","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.23889\/ijpds.v8i1.2151","article-title":"Overcoming ethical and legal obstacles to data linkage in health research: stakeholder perspectives","volume":"8","author":"Smit","year":"2023","journal-title":"Int J Popul Data Sci"},{"key":"2026083104014561400_lgag009-B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: predictive values","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"2026083104014561400_lgag009-B29","doi-asserted-by":"publisher","first-page":"e2115321","DOI":"10.1001\/jamanetworkopen.2021.15321","article-title":"Modeling cervical cancer screening strategies with varying levels of human papillomavirus vaccination","volume":"4","author":"Grimes","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026083104014561400_lgag009-B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-023-02748-3","article-title":"Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis","volume":"21","author":"Choi","year":"2023","journal-title":"BMC Med"},{"key":"2026083104014561400_lgag009-B31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw216","article-title":"Optimal cervical cancer screening in women vaccinated against human papillomavirus","volume":"109","author":"Kim","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2026083104014561400_lgag009-B32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ijc.31094","article-title":"What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study","volume":"142","author":"Landy","year":"2018","journal-title":"Int J Cancer"},{"key":"2026083104014561400_lgag009-B33","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"key":"2026083104014561400_lgag009-B34","doi-asserted-by":"publisher","first-page":"e0145548","DOI":"10.1371\/journal.pone.0145548","article-title":"Cervical cancer screening in partly HPV vaccinated cohorts: a cost-effectiveness analysis","volume":"11","author":"Naber","year":"2016","journal-title":"PLoS One"},{"key":"2026083104014561400_lgag009-B35","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1002\/ijc.30392","article-title":"Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries","volume":"139","author":"Simms","year":"2016","journal-title":"Int J Cancer"},{"key":"2026083104014561400_lgag009-B36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hec.1397","article-title":"Transferability indices for health economic evaluations: methods and applications","volume":"18","author":"Antonanzas","year":"2009","journal-title":"Health Econ"},{"key":"2026083104014561400_lgag009-B37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1185\/030079906x167327","article-title":"Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another","volume":"23","author":"Goeree","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"2026083104014561400_lgag009-B38","doi-asserted-by":"publisher","first-page":"e035796","DOI":"10.1136\/bmjopen-2019-035796","article-title":"Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol","volume":"10","author":"Almonte","year":"2020","journal-title":"BMJ Open"},{"key":"2026083104014561400_lgag009-B39","author":"Bruni","year":"10,"},{"key":"2026083104014561400_lgag009-B40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ije\/dyt049","article-title":"Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis","volume":"42","author":"Fisher","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2026083104014561400_lgag009-B41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","article-title":"Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review","volume":"22","author":"Petersen","year":"2022","journal-title":"BMC Womens Health"},{"key":"2026083104014561400_lgag009-B42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"2026083104014561400_lgag009-B43","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1080\/21645515.2018.1564438","article-title":"Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction","volume":"15","author":"Covert","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2026083104014561400_lgag009-B44","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","article-title":"Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"key":"2026083104014561400_lgag009-B45","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the Costa Rica vaccine trial","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncol"},{"key":"2026083104014561400_lgag009-B46","author":"Calderon","year":"2023"},{"key":"2026083104014561400_lgag009-B47","author":"World Population Prospects"},{"key":"2026083104014561400_lgag009-B48","author":"Campbell","year":"2024"},{"key":"2026083104014561400_lgag009-B49","doi-asserted-by":"publisher","first-page":"1073274821997497","DOI":"10.1177\/1073274821997497","article-title":"The prevalence and associated factors of cancer screening uptake among a national population-based sample of adults in Marshall Islands","volume":"28","author":"Pengpid","year":"2021","journal-title":"Cancer Control"},{"key":"2026083104014561400_lgag009-B50","author":"UNFPA in Eastern Europe and Central Asia, International Cervical Cancer Prevention Association"},{"key":"2026083104014561400_lgag009-B51","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejogrb.2023.08.385","article-title":"Provision of screening services for cervical and breast cancer: a scientific study commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG)","volume":"289","author":"Vieira-Coimbra","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2026\/73\/155\/70870267\/lgag009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2026\/73\/155\/70870267\/lgag009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:01:53Z","timestamp":1788163313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncimono\/article\/2026\/73\/155\/8776091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":51,"journal-issue":{"issue":"73","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgag009","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"value":"1052-6773","type":"print"},{"value":"1745-6614","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8,1]]}}}